• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home StudyGraphics

#VisualAbstract: Comparison of Cardiovascular and Safety Outcomes of Chlorthalidone vs Hydrochlorothiazide to Treat Hypertension

byConstance Wu
April 25, 2020
in StudyGraphics
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

RELATED REPORTS

#VisualAbstract: Dapagliflozin associated with reduced risk of cardiovascular and kidney outcomes irrespective of background use of cardiovascular medications

Treating mild chronic hypertension associated with better pregnancy outcome

Radiofrequency renal denervation produces long-lasting reductions in blood pressure

1. While chlorthalidone is the recommended thiazide diuretic treatment for hypertension, it has no added benefits compared to hydrochlorothiazide and has significantly worse safety profile.

Evidence Rating Level: 1 (Excellent)

The American College of Cardiology/American Heart Association hypertension guideline reported in 2017 that the recommended thiazide diuretic treatment for hypertension is currently chlorthalidone. However, there are insufficient trials investigating risks and benefits. This Large-Scale Evidence Generation and Evaluation in a Network of Databases (LEGEND) observational, comparative cohort study sought to investigate the cardiovascular and safety outcomes of chlorthalidone and hydrochlorothiazide as first-line treatments for hypertension. Of 730,225 individuals (M [SD] age, 51.5 [13.3] years, 61.6% female), 36,918 were prescribed chlorthalidone with 149 composite outcome events and 693,337 were prescribed hydrochlorothiazide with 3,089 composite outcome events. No significant differences were found in associated risks of stroke, hospitalized heart failure, or myocardial infarction. The hazard ratio for composite cardiovascular outcomes was 1.00 for chlorthalidone compared to hydrochlorothiazide (95% CI 0.85 to 1.17). Chlorthalidone was associated with significantly elevated risks of type 2 diabetes (HR, 1.21, 95% CI 1.12-1.30), chronic kidney disease (HR, 1.24, 95% CI 1.09 to 1.42), acute renal failure (HR, 1.37, 95% CI 1.15 to 1.63), hyponatremia (HR, 1.31, 95% CI 1.16 to 1.47), and hypokalemia (HR, 2.72, 95% CI 2.38 to 3.12). However, chlorthalidone was also associated with a lower risk of abnormal weight gain (HR, 0.73, 95% CI 0.61 to 0.86). This study highlights concerns related to the preferred treatment for hypertension, such that chlorthalidone use not only resulted in non-significant cardiovascular benefits compared to hydrochlorothiazide but was associated with significantly greater risks of metabolite and renal abnormalities.

Click to read the study in JAMA Internal Medicine

©2020 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: chlorthalidoneHigh Blood Pressurehydrochlorothiazidehypertension
Previous Post

Lung ultrasound may be useful in managing children with COVID-19

Next Post

Adverse neurodevelopmental outcomes linked to prenatal exposure to antidepressants

RelatedReports

#VisualAbstract: Dapagliflozin associated with reduced risk of cardiovascular and kidney outcomes irrespective of background use of cardiovascular medications
StudyGraphics

#VisualAbstract: Dapagliflozin associated with reduced risk of cardiovascular and kidney outcomes irrespective of background use of cardiovascular medications

August 10, 2022
Prenatal antidepressant exposure may increase risk of poor motor development
Cardiology

Treating mild chronic hypertension associated with better pregnancy outcome

May 13, 2022
Tenofovir disoprovil fumarate HIV prophylaxis linked with minimal kidney impact
Cardiology

Radiofrequency renal denervation produces long-lasting reductions in blood pressure

April 20, 2022
Parental nonmedical prescription opioid use linked to adolescent use
Cardiology

Intensive blood pressure control associated with increased cerebral blood flow in patients with hypertension – the SPRINT trial

March 8, 2022
Next Post
Large proportion of late preterm infants and older admitted to the NICU

Adverse neurodevelopmental outcomes linked to prenatal exposure to antidepressants

Cognitive outcomes in older adults undergoing cardiovascular procedures unclear

Bypass grafting versus stenting for patients with severely reduced ejection fraction

Pediatric renal and thyroid cancer rates increase

2 Minute Medicine Rewind April 27, 2020

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Combined genetic testing of cardiomyopathies and arrhythmias increases diagnostic yield to inform patient management
  • Provision of 1-year mortality data for patients hospitalized with heart failure does not influence clinical decision-making – The REVEAL-HF trial
  • Genetic risk for hemochromatosis associated with abnormal iron deposition localized to motor circuits of the brain
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.